From what 7 stock analysts predict, the share price for Sage Therapeutics Inc (SAGE) might increase by 1.93% in the next year. This is based on a 12-month average estimation for SAGE. Price targets go from $20.00 to $30.00. The majority of stock analysts believe SAGE is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
SAGE is a stock in Health Care which has been forecasted to be worth $24.29 as an average. On the higher end, the forecast price is $30.00 USD by ritu baral from TD Cowen and on the lower end SAGE is forecasted to be $20.00 by vikram purohit from Morgan Stanley.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
ritu baral TD Cowen | Buy | $30.0 | maintained | Jan 9, 2024 |
george farmer Scotiabank | Buy | $24.0 | rated | Nov 8, 2023 |
anupam rama J.P. Morgan | Buy | $24.0 | maintained | Aug 22, 2023 |
yasmeen rahimi Piper Sandler | Buy | $100.0 | rated | Aug 7, 2023 |
andrew tsai Jefferies | Buy | $100.0 | maintained | Jun 19, 2021 |
cory kasimov J.P. Morgan | Buy | $101.0 | maintained | Feb 24, 2021 |
michael yee Jefferies | Buy | $195.0 | maintained | Oct 17, 2019 |
tim rezvan Oppenheimer | Buy | $170.0 | maintained | Nov 1, 2018 |
edward nash Canaccord Genuity | Buy | $203.0 | reiterated | Feb 27, 2018 |
john newman Canaccord Genuity | Buy | $191.0 | maintained | Feb 22, 2018 |
adam walsh Stifel Nicolaus | Buy | $198.0 | reiterated | Dec 7, 2017 |
michael gibbs Raymond James | Buy | $87.0 | rated | Nov 2, 2017 |
keith gay Stifel Nicolaus | Buy | $104.0 | initiatedcoverage | Aug 9, 2017 |
john ransom Raymond James | Buy | $102.0 | rated | Aug 3, 2017 |
christopher raymond Piper Sandler | Buy | $102.0 | maintained | Jun 26, 2017 |
katherine breedis Stifel Nicolaus | Buy | $90.0 | initiatedcoverage | Nov 14, 2016 |
navdeep singh Goldman Sachs | Buy | $80.0 | initiatedcoverage | May 15, 2015 |
In 2023, SAGE generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SAGE's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11